INVO Fertility Stock-Based Compensation Growth & History (IVF)
INVO Fertility's stock-based compensation was $162,920 for fiscal 2025.
View full INVO Fertility company overviewINVO Fertility annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $162,920 | −$1.4M | −89.75% |
| 2024 | 2024-12-31 | $1.6M | $196,151 | +14.08% |
| 2023 | 2023-12-31 | $1.4M | −$222,906 | −13.79% |
| 2022 | 2022-12-31 | $1.6M | $72,489 | +4.70% |
| 2021 | 2021-12-31 | $1.5M | $402,923 | +35.31% |
| 2020 | 2020-12-31 | $1.1M | $1.1M | +1534.96% |
| 2019 | 2019-12-31 | $69,787 | $69,787 | — |
| 2018 | 2018-12-31 | $0 | — | — |
INVO Fertility quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $189,492 | −$491,188 | −72.16% |
| Q1 2026 | 2026-03-31 | $94,311 | $23,656 | +33.48% |
| Q4 2025 | 2025-12-31 | $224,528 | — | — |
| Q3 2025 | 2025-09-30 | $493,348 | — | — |
| Q2 2025 | 2025-06-30 | $680,680 | — | — |
| Q1 2025 | 2025-03-31 | $70,655 | — | — |
| Q3 2023 | 2023-09-30 | $251,555 | −$174,588 | −40.97% |
| Q2 2023 | 2023-06-30 | $326,916 | −$105,880 | −24.46% |
| Q1 2023 | 2023-03-31 | $325,834 | −$102,654 | −23.96% |
| Q4 2022 | 2022-12-31 | $328,974 | −$63,138 | −16.10% |
| Q3 2022 | 2022-09-30 | $426,143 | $34,949 | +8.93% |
| Q2 2022 | 2022-06-30 | $432,796 | $48,713 | +12.68% |
| Q1 2022 | 2022-03-31 | $428,488 | $51,965 | +13.80% |
| Q4 2021 | 2021-12-31 | $392,112 | $103,310 | +35.77% |
| Q3 2021 | 2021-09-30 | $391,194 | $135,397 | +52.93% |
| Q2 2021 | 2021-06-30 | $384,083 | $169,168 | +78.71% |
| Q1 2021 | 2021-03-31 | $376,523 | −$4,952 | −1.30% |
| Q4 2020 | 2020-12-31 | $288,802 | $219,015 | +313.83% |
| Q3 2020 | 2020-09-30 | $255,797 | $255,797 | — |
| Q2 2020 | 2020-06-30 | $214,915 | $214,915 | — |
| Q1 2020 | 2020-03-31 | $381,475 | $381,475 | — |
| Q4 2019 | 2019-12-31 | $69,787 | — | — |
| Q3 2019 | 2019-09-30 | $0 | — | — |
| Q2 2019 | 2019-06-30 | $0 | −$1.6M | — |
| Q1 2019 | 2019-03-31 | $0 | −$181,664 | — |
| Q2 2018 | 2018-06-30 | $1.6M | $1.5M | +3147.05% |
| Q1 2018 | 2018-03-31 | $181,664 | $122,422 | +206.65% |
| Q3 2017 | 2017-09-30 | $28,589 | $28,589 | — |
| Q2 2017 | 2017-06-30 | $48,099 | −$1.2M | −96.19% |
| Q1 2017 | 2017-03-31 | $59,242 | $59,242 | — |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $1.3M | $1.3M | — |
| Q1 2016 | 2016-03-31 | $0 | $0 | — |
| Q3 2015 | 2015-09-30 | $0 | — | — |
| Q2 2015 | 2015-06-30 | $0 | — | — |
| Q1 2015 | 2015-03-31 | $0 | $0 | — |
| Q1 2014 | 2014-03-31 | $0 | −$60,000 | — |
| Q1 2013 | 2013-03-31 | $60,000 | $60,000 | — |
| Q1 2012 | 2012-03-31 | $0 | — | — |
| Q3 2011 · Sep 30 | 2010-09-30 | $0 | — | — |
INVO Fertility stock-based compensation trends
Over the last five fiscal years, INVO Fertility's stock-based compensation decreased from $1.1M to $162,920, a change of −$978,069. The latest reported quarter, Q2 2026, shows $189,492.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review INVO Fertility source filings ↗